Developer of gene-edited crop traits spun out of Cellectis.
Industry: Health Care
First Day Return: +40.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/23/2017 |
Offer Price | $8.00 |
Price Range $8.00 - $10.00 | |
Offer Shares (mm) | 7.0 |
Deal Size ($mm) | $56 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/19/2017 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $56 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | New Brighton, MN, United States |
Founded | 2010 |
Employees at IPO | 27 |
Website www.calyxt.com |